Genome Editing Genome Engineering Market - Trends Forecast Till 2028

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: November, 2021

Base Year Estimate: 2020

Report ID: D-PH-GEM-406


Number of Pages: 382

Domain: Pharmaceutical

Genome Editing/Genome Engineering Market – Trends Forecast Till 2028

Genomic engineering is the synthetic assembly of complete chromosomal DNA that is more or less derived from natural genomic sequences.

The global genome editing/genome engineering market is projected to USD 11.7 billion by 2026 from USD 5.1 billion in 2021, at a CAGR of 18.2 % between 2021 and 2028.

Recent improvements in this field have led to significant developments in the genome editing capabilities and it has enabled the modification of gene sequences of interest in a wide variety of cell types and model organisms and the shift from academics to clinical and diagnostic laboratories is primarily driven by improvements in gene editing technologies are some of the factors that have supported long-term expansion for Genome Editing/Genome Engineering Market.

The COVID-19 pandemic has prompted key pharmaceutical and biotechnology companies, as well as players in the genomic market, to invest in vaccine R&D. The rise in demand for vaccines and potential antiviral candidates has brought genome editing/engineering technologies to the forefront.

Genome Engineering Market Report

North America accounted for the largest share of this market, followed by Europe in 2020. The key factors helping in the growth of the market in North America include the development of gene therapy, increased use of GM crops, and a rise in the availability of research grants and funding in the US. The market in Canada is expected to witness growth in the coming years owing to various government initiatives and the intensification of genomics R&D (through GAPP) in the country.

Genome Editing/Genome Engineering Market is segmented into product and services, technology, application, end user and region.

On the basis of Product & Services

  • Reagents & consumables
  • Software & systems
  • Services

On the basis of Technology

  • ZFN
  • Antisense
  • Other technologies

On the basis of Application

  • Cell Line Engineering
  • Genetic Engineering
  • Diagnostic applications
  • Drug discovery & development
  • Other applications

On the basis of End-Users

  • Biotechnology companies
  • Pharmaceutical companies
  • Academic & Government Research Institutes

Insights are provided for each region and major countries within the regions

Genome Engineering Market Primary Respondents

Key Players

  • Thermo Fisher Scientific Inc.
  •  Merck KGaA
  •  GenScript

Recent Developments

  • In October 2021, Merck KGaA licensed its patented CRISPR-Cas9 technology to Cellecta for the development of next-generation treatments, which has allowed researchers and scientists to advance treatments for genetic blood disorders, cancers, and ophthalmological diseases.
  • In May 2019, Thermo Fisher Scientific acquired Brammer Bio to increase its global presence in the market with the addition of the expertise of Brammer Bio in the manufacturing of vectors for genes and cell therapies.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Genome Editing/Genome Engineering Marketso as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope


Report Feature


Market Revenue In 2021

USD 5.1 billion

Growth Rate

CAGR of 18.2% during the forecasting period, 2021-2026

Historical Data


Forecast Years


Base Year


Units Considered

Revenue in USD billion and CAGR from 2021 to 2026

Report Segmentation

Product & services, technology, application, end user and region.

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Thermo Fisher Scientific Inc., Merck KGaA and GenScript.

Available Customization

In addition to the market data for Genome Editing/Genome Engineering Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.

Regional Report

Note: Report data and information will be by Country.

Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.